Intrinsic Value

Navidea Biopharmaceuticals, Inc. (NAVB)

$0.0375

+0.00 (+1.90%)

Enterprise Value -442,341.19
Net Debt 0.44
Equity Value -442,341.62
Shares Outstanding 29.34
Equity Value Per Share -15,074.58



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt